Amplified CD38−/low NK cells derived from Dara-treated patients proliferated efficiently in vitro, exhibited increased lytic toxicity against MM.1S cells, and significantly improved the survival of mice (Wang et al., 2018). Here, CD38 is linked to Miyoshi myopathy.